Theodore J. Alkousakis, MD, FAAD
SESSIONS
S043 The Quality Improvement and Innovation Symposium
Mar 9, 2025
•
1:00 PM - 4:00 PM
•
W304H
DISCLOSURES
Eli Lilly – Stockholder Public Company(No Compensation Received); Johnson & Johnson Innovative Medicine – Employee (w-2 relationship)(Salary), Employee (w-2 relationship)(Stock), Employee (w-2 relationship)(Stock Options);